William Mohlenbrock, MD, founder and CMO of Verras and a practicing orthopedic surgeon at Scripps Memorial Hospital in La Jolla, Calif., discussed physician variation in a recent webinar presented by ...
Using novel therapies, physician-investigators at Miami Cancer Institute, part of Baptist Health, are conducting important cutting-edge clinical research in the battle against cancer. Their hope is ...
On this episode of Ropes & Gray’s podcast series Non-binding Guidance, health care partner David Peloquin and life sciences regulatory and compliance counsel Sarah Blankstein discuss the FDA's recent ...
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the strategic ...
After Delos “Toby” Cosgrove took over as CEO of Cleveland Clinic in 2005, he led the charge to create a more patient-centered health system and introduced the Clinic’s “Patients First” initiative. In ...
Nuwellis, Inc. has announced the termination of its REVERSE-HF clinical trial, which was evaluating the use of ultrafiltration versus IV loop diuretics for managing fluid in heart failure patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results